CALC CIK: 1534133

CalciMedica, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
67.1
FY22:
1.73
FY23:
11.6
FY24:
19.7
FY25:
13.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
2.01
FY22:
1.62
FY23:
0.58
FY24:
0.13
FY25:
0.06
Total assets
Change from FY21 to FY25
millions USD
FY21:
69.1
FY22:
3.35
FY23:
12.2
FY24:
19.8
FY25:
13.6

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
4.06
FY22:
4.78
FY23:
4.03
FY24:
3.68
FY25:
3.78
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.01
FY22:
7.80
FY23:
0
FY24:
1.70
FY25:
16.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
65.0
FY22:
−71.3
FY23:
8.16
FY24:
14.4
FY25:
−6.64
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
69.1
FY22:
–
FY23:
12.2
FY24:
19.8
FY25:
13.6

All amounts in millions USD Data sources:SEC EDGARTwelve Data